Hilberg, Frank <br/><br/>
Triple Angiokinase Inhibitor Nintedanib Directly Inhibits Tumor Cell Growth and Induces Tumor Shrinkage via Blocking Oncogenic Receptor Tyrosine Kinases.  [electronic resource] 

 -  The Journal of pharmacology and experimental therapeutics  03 2018 
 - 494-503 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1521-0103 
<br/><br/><label>Standard No.: </label>10.1124/jpet.117.244129  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Carcinoma, Non-Small-Cell Lung--pathology<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Humans<br/>Indoles--pharmacology<br/>Lung Neoplasms--pathology<br/>Mice<br/>Mutation<br/>Oncogenes--genetics<br/>Protein Kinase Inhibitors--pharmacology<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Proto-Oncogene Mas<br/>Tumor Burden--drug effects<br/>Xenograft Model Antitumor Assays